Ozempic

Published research on Ozempic.

DrugsJul 12, 2026

GLP-1 Drugs Linked to 21% Higher Daytime Sleepiness Risk

GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) act on the brain as well as the gut, and a 2026 real-world cohort study from Kamel-Abusalha et al. propensity-matched 118,993 …

Read article →

DrugsMay 25, 2026

GLP-1 Weight-Loss Drugs Triggered Effort-Based Stigma in 4 Studies

A 2026 Scientific Reports paper involving 1,205 participants found that people using GLP-1-style weight-loss medication were judged as less effortful, less moral, less competent, less warm, …

Read article →

Neurodegenerative DiseasesApr 30, 2026

GLP-1 Drugs for Parkinson’s: Lixisenatide Signal, Exenatide Miss

Parkinson’s disease is the second most common neurodegenerative disorder, affecting around 10 million people worldwide. The mental-health burden is heavy: depression affects 40-50% of patien…

Read article →